Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

481 - 490 of 785 results found

Optimizing the use of vilobelimab for the treatment of COVID-19

Date
Saturday, July 08, 2023 - 4:00 AM
Description
INTRODUCTION: On 4 April 2023, the United States Food and Drug Administration issued an emergency use authorization for the use of vilobelimab (Gohibic^(TM)) for the treatment of COVID-19 in hospitalized adults when initiated within 48 hours of

Organokines in COVID-19: A Systematic Review

Date
Thursday, July 06, 2023 - 4:00 AM
Description
Coronavirus disease 2019 (COVID-19) is a viral infection caused by SARS-CoV-2 that induces a generalized inflammatory state. Organokines (adipokines, osteokines, myokines, hepatokines, and cardiokines) can produce beneficial or harmful effects in